We are pleased to announce the next meeting of the Expanded Access Summit ® will take place in the Spring of 2025!
The Expanded Access Summit® is the world’s largest annual conference on pre-market access to medicines. The Summit focuses on the core feasibility factors and the innovations that enable greater use of Expanded Access and other "treatment-use" trials. Join us at EA5-Virtual as we again set new best practices for integrating research into modern healthcare for everyone.
Janet Woodcock, MD; FDA
Expanded Access 3.0, January 28, 2020
Hilary Marston, MD, MPH; NIAID, NIH
Expanded Access 3.0, January 28, 2020
Michael Kurilla, MD, PhD; NCATS, NIH
Expanded Access 3.0, January 28, 2020
The Expanded Access Summit® was launched in 2017 to provide a best-practices forum for thought leaders from the highest level of leadership in industry, clinical care, patient advocacy, and government. It has since become the world’s largest and most influential annual conference on pre-market access to medicines.
Each year the Summit examines the four major feasibility factors of pre-market access:
Operational efficiency
Learning outcomes and research value
Financial collaboration, cost recovery, and reimbursement from payers
Alignment with healthcare delivery organizations
Previous Speakers Include:
Janet WoodCock, MD
Acting Commissioner, FDA
Toni Fauci, MD
Director, National Institute of Allergy and Infectious Diseases (NIAID), NIH
Chris Austin, MD
Former Director, National Center for Advancing Translational Sciences, NIH
Robert Walker, MD
Director, Division of Clinical Development, Biomedical Advanced Research and Development Authority (BARDA), HHS
Marjorie Speers, PhD
Executive Director, Clinical Research Pathways
MICHAEL KURILLA, MD, PHD
Director of the Division of Clinical Innovation, NCATS-NIH
MARC BOUTIN, JD
Former Chief Executive Officer, National Health Council
SUANNA BRUINOOGE, MPH
Director of Research Strategy, CENTRA, American Society of Clinical Oncology (ASCO)
Register Now
Expanded Access 4.0 (virtual conference)
2021
The 4th Annual Expanded Access Summit®
The Leading Global Forum on Pre-Market Access to Medicines
| Type |
Early-Bird Pricing Through July 15, 2021 |
Standard Pricing |
|---|---|---|
| Corporate | $750 | $1100 |
| Health System / Government / Non-Profit | $200 | $250 |
|
Member of the Public / Guest Pass (No partnering meetings, no affiliation displayed) |
$50 | $60 |
| Entrepreneur | Contact Us | Contact Us |
- Four hours of live programming each day
- Access to “on-demand” premium content (explainers, case interviews, etc.)
- Separate “Innovator Showcase” presentations at the end of each live broadcast
- Interactive exhibits
- Breakout chat and discussion groups
- One-on-One Partnering event
Sponsors and Partners
